Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia-Reference-Cited by-同舟云学术

Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia

Published:2018-01 Issue:1 Volume:2 Page:e29
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Blouet Anaïse,Rousselet Marie-Christine,Le Bris Yannick,Ribourtout Bénédicte,Bouvier Anne,Cottin Laurane,Jouanneau-Courville Rébecca,Blanchet Odile,Ugo Valérie,Luque Paz Damien

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference10 articles.

1. Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference;Barosi;Blood,2009

2. JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens;Mansier;Leuk Lymphoma,2016

3. A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm;Cabagnols;N Engl J Med,2015

4. CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation;Bonzheim;Blood,2015

5. Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1;Loghavi;Blood,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloproliferative neoplasms with concomitant CALR mutation and BCR::ABL1 translocation: diagnostic and therapeutic implications of a rare hybrid disease;Frontiers in Cell and Developmental Biology;2024-03-26

2. Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review;Cancer Research and Treatment;2020-07-15

3. CONCURRENT CHRONIC MYELOID LEUKEMIA AND CALR-MUTATED MYELOPROLIFERATIVE NEOPLASM;EXCLI J;2020

4. Imatinib;Reactions Weekly;2019-10